Donor-derived bacteremia in liver transplant recipients despite antibiotic prophylaxis

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 1080-1083

  Doucette, K E ^a   Al Saif, M ^a   Kneteman, N ^a   Chui, L ^a   Tyrrell, G J ^a   Kumar, D ^a,b   Humar, A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

Bacterial infection; donor to host transmission; infectious complications; liver transplantation

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BILE LEAKAGE; BLOOD CULTURE; CASE REPORT; CHILD; DISEASE TRANSMISSION; ESCHERICHIA COLI; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; ESCHERICHIA COLI; FEMALE; HUMANS; INFANT; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TISSUE DONORS;

EID: 84875756196     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12133     Document Type: Article

References (15)

1. Wolfe RA, Roys EC, Merion RM,. Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 10 (4 Pt 2): 961-972.
2. Nelson PW, Delmonico FL, Tolkoff-Rubin NE, et al. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37: 313-314. (Pubitemid 14164950)
3. Freeman RB, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999; 68: 1107-1111. (Pubitemid 29517698)
4. Lumbreras C, Sanz F, Gonzalez A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001; 33: 722-726. (Pubitemid 32762948)
5. Mulvey MR, Chui L, Ismail J, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001; 39: 3481-3485. (Pubitemid 32954488)
6. Garzoni C, Ison MG,. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation 92: 1297-1300.
7. Grossi PA, Fishman JA,. Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S19-26.
8. Fischer SA, Avery RK,. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9 (Suppl 4): S7-18.
9. Bull DA, Stahl RD, McMahan DL, et al. The high risk heart donor: Potential pitfalls. J Heart Lung Transplant 1995; 14: 424-428.
10. Doig RL, Boyd PJ, Eykyn S,. Staphylococcus aureus transmitted in transplanted kidneys. Lancet 1975; 2 (7928): 243-245.
11. Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation. Liver Transpl 2006; 12: 1253-1259. (Pubitemid 44194594)
12. Gao B, Jeong WI, Tian Z,. Liver: An organ with predominant innate immunity. Hepatology 2008; 47: 729-736. (Pubitemid 351280741)
13. Hosein S, Udy AA, Lipman J,. Physiological changes in the critically ill patient with sepsis. Curr Pharma Biotech 2011; 12: 1991-1995.
14. Christ W,. Pharmacological properties of cephalosporins. Infection 1991; 19 (Suppl 5): S244-252.
15. Martins N, Martins IS, de Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transplant Infect Dis 2012; 14: 316-320.